Shares of Natus Medical Inc (NASDAQ:BABY) have earned an average recommendation of “Hold” from the five ratings firms that are covering the firm. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $55.00.
Several brokerages have recently weighed in on BABY. Zacks Investment Research upgraded shares of Natus Medical from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research report on Wednesday, January 11th. Raymond James Financial, Inc. downgraded shares of Natus Medical from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 2nd.
Shares of Natus Medical (NASDAQ:BABY) traded up 1.37% during midday trading on Monday, hitting $40.70. 122,943 shares of the stock traded hands. The company has a market cap of $1.32 billion, a price-to-earnings ratio of 31.55 and a beta of 1.02. The stock has a 50-day moving average of $38.34 and a 200-day moving average of $38.44. Natus Medical has a 52-week low of $31.19 and a 52-week high of $44.39.
Natus Medical (NASDAQ:BABY) last issued its quarterly earnings data on Wednesday, February 1st. The medical equipment provider reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.53 by $0.02. The company had revenue of $107.70 million for the quarter, compared to analysts’ expectations of $107.58 million. Natus Medical had a return on equity of 13.24% and a net margin of 11.11%. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.51 EPS. On average, equities analysts predict that Natus Medical will post $1.79 earnings per share for the current fiscal year.
In related news, Director Robert A. Gunst sold 5,000 shares of the company’s stock in a transaction on Thursday, February 9th. The shares were sold at an average price of $36.00, for a total value of $180,000.00. Following the completion of the sale, the director now owns 56,150 shares in the company, valued at approximately $2,021,400. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 4.80% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in the stock. Norges Bank acquired a new stake in Natus Medical during the fourth quarter valued at approximately $11,560,000. Columbia Wanger Asset Management LLC increased its stake in Natus Medical by 123.0% in the fourth quarter. Columbia Wanger Asset Management LLC now owns 590,825 shares of the medical equipment provider’s stock valued at $20,561,000 after buying an additional 325,825 shares during the period. Numeric Investors LLC increased its stake in Natus Medical by 2,499.6% in the fourth quarter. Numeric Investors LLC now owns 233,960 shares of the medical equipment provider’s stock valued at $8,142,000 after buying an additional 224,960 shares during the period. Bogle Investment Management L P DE acquired a new stake in Natus Medical during the fourth quarter valued at approximately $7,233,000. Finally, Lyon Street Capital LLC increased its stake in Natus Medical by 45.7% in the fourth quarter. Lyon Street Capital LLC now owns 456,016 shares of the medical equipment provider’s stock valued at $15,869,000 after buying an additional 142,936 shares during the period. Hedge funds and other institutional investors own 80.27% of the company’s stock.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2065210/natus-medical-inc-baby-receives-55-00-average-pt-from-analysts.html
Receive News & Ratings for Natus Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.